Assay Kits

Assay kits are used to carry out analyses in a broad scope of applications including the study of targets such as drugs, molecules, disease pathways, chemical elements or compounds, and organisms. They are a routine procedure in the modern pharmaceutical, medical and forensic world as well as research and university laboratories around the globe. Assay kits come with all the necessary reagents, instructions and protocols for fast and efficient processing, allowing for repeatable results.
CompanyIBL-AmericaIBL-AmericaIBL-AmericaIBL-AmericaIBL-America
ItemBevacizumab (Avastin®) ELISAAmyloid Beta (1-42) ELISA AssayBordetella pertussis IgG ELISAIGFBP-3 RIA-CT AssayProinsulin (Intact) LUM Assay
Citations
Catalog NumberTM0901027711IB79850IGF-R11IV2-002
PriceSupplier PageSupplier PageSupplier PageSupplier PageSupplier Page
DescriptionEnzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Bevacizumab (Avastin®) in serum and plasma. For research use only, not for use in diagnostic procedures.Solid phase sandwich ELISA for the determination of human Aß(1-42) in cerebrospinal fluid, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures.The Bordetella pertussis IgG ELISA is intended for the determination of IgG class antibodies against Bordetella pertussis in human serum or plasma (citrate, heparin). For research use only, not for use in diagnostic procedures.Radioimmunoassay (RIA) for the determination of human IGFBP-3 in serum, plasma, or other human biological fluids (e.g. follicular fluid, seminal plasma). For research use only, not for use in diagnostic procedures.The Invitron Intact Proinsulin luminescence assay is an immunometric assay (LUM) for the quantitative measurement of intact proinsulin in human plasma samples. Measurements of proinsulin are used in the diagnosis and treatment of patients with type 2 diabetes. FDA exempt, can be used for in-vitro ... Read More
Detection TargetBevacizumab (Avastin®)Anti-Infliximab (Remicade®, Remsima®, and Inflectra®) (ATI)Secretoneurin (Human)GLP-1, Active FormIGFBP-3
Sample TypeSerum and plasma.Serum and plasma.Serum, Blood PlasmaBlood Plasma, Cell Culture SupernatantSerum, Blood Plasma, Follicular Fluid, Seminal Blood Plasma
MethodEnzyme-Linked Immunosorbent Assay (ELISA)Enzyme-Linked Immunosorbent Assay (ELISA)Enzyme-Linked Immunosorbent Assay (ELISA)Radio Immuno Assay (RIA)Luminescence (LUM) Assay
Detection Range0 / 6 to 200 ng/mL12.5 to 800 pg/mLA cut-off control is used for the interpretation of results.1 to 81 ng/mL1.5 to 110.0 pmol/L
Sensitivity2 ng/mL1 ng/mL7.6 pmol/L0.09 pmol/L0.5 ng/mL
Assay Time1 hour, 45 min. total incubation time.Overnight + 1 hr 30 mins (incubation)1 hr 45 mins (incubation)63 hrs (incubation)3 hrs (incubation)
Get QuoteSupplier PageSupplier PageSupplier PageSupplier PageSupplier Page

Articles